Single-session radiofrequency ablation versus microwave ablation of predominantly solid benign thyroid nodules-a comparison after propensity score matching for initial nodule volumes and diameters.

The comparative efficacy of single-session radiofrequency ablation (RFA) versus microwave ablation (MWA) for benign solid thyroid nodules remains unclear because existing literature consists of heterogenous baseline and wide range of nodule volumes. This study identified the predictors of volume reduction rate (VRR) of RFA versus MWA, and compared the efficacy between the two treatments. Consecutive benign nodules ≥ 80% solid, treated with a single session of RFA or MWA in a tertiary endocrine surgery center, with at least 12-month follow-up, were included. Propensity score matching (PSM) for baseline characteristics was performed to compare RFA vs MWA. The primary outcome was 12-month VRR. From 2021 to 2023, 208 nodules were analyzed (RFA: 142, MWA: 66). Maximum nodule diameter and initial nodule volume correlated with 12-month VRR (p < 0.001, correlation coefficient -0.360 and -0.322, respectively) of RFA but not MWA. PSM analysis for age, sex and maximum nodule diameter; or age, sex and initial nodule volume showed comparable overall 12-month VRR between RFA and MWA. In subgroup analysis, MWA achieved greater 3-month and 12-month (78.0% ± 15.5 vs 67.3% ± 17.6, p = 0.028) VRR for nodules with a maximum diameter ≥ 3.5 cm; and greater 6-month VRR for nodules with volume ≥ 20 mL (71.4% ± 16.7 vs 57.2% ± 16.1, p = 0.030). No significant complications occurred in either ablation modality. Larger nodule diameter and volume negatively correlated with the treatment efficacy of single-session RFA, but not MWA. Single-session MWA achieved greater VRR for nodules with maximum diameter ≥ 3.5 cm, or volume ≥ 20 mL. The results of this study prompt confirmation by future randomized controlled trials with stratification by nodule volume. Question The comparative efficacy of single-session radiofrequency ablation (RFA) versus microwave ablation (MWA) for benign solid thyroid nodules remains unclear and so are factors affecting treatment efficacy. Findings Larger nodule diameter and volume negatively correlated with efficacy of RFA. For smaller nodules, RFA and MWA were comparable. MWA may have better efficacy for larger nodules. Clinical relevance For smaller nodules (max diameter < 3.5 cm or volume < 20 mL), RFA and MWA were equally effective and safe. For larger nodules (max diameter ≥ 3.5 cm or volume ≥ 20 mL), MWA may be more efficacious. Verification with prospective trials that account for baseline nodule volumes is needed.